138 related articles for article (PubMed ID: 37985605)
1. Unveiling the Influence of a High-Fat Meal on the Pharmacokinetics of Oral Globalagliatin, A Glucokinase Activator, in Healthy Chinese Volunteers.
Xu M; Wang Y; Wang X; Pu Z; Liu Y; Jiang C; Shen X; Sun H; Xie H
Drugs R D; 2024 Mar; 24(1):41-50. PubMed ID: 37985605
[TBL] [Abstract][Full Text] [Related]
2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
3. Safety, Pharmacokinetics, and Pharmacodynamics of Globalagliatin, a Glucokinase Activator, in Chinese Patients with Type 2 Diabetes Mellitus: A Randomized, Phase Ib, 28-day Ascending Dose Study.
Zheng S; Shao F; Ding Y; Fu Z; Fu Q; Ding S; Xie L; Chen J; Zhou S; Zhang H; Zhou H; Chen Y; Sun C; Zhu J; Zheng X; Yang T
Clin Drug Investig; 2020 Dec; 40(12):1155-1166. PubMed ID: 33125674
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence and pharmacokinetic evaluation of two formulations of risperidone 2 mg : an open-label, single-dose, fasting, randomized-sequence, two-way crossover study in healthy male Chinese volunteers.
Liu Y; Zhang MQ; Jia JY; Liu YM; Liu GY; Li SJ; Wang W; Weng LP; Yu C
Drugs R D; 2013 Mar; 13(1):29-36. PubMed ID: 23322527
[TBL] [Abstract][Full Text] [Related]
5. Effects of food on the pharmacokinetics of ponatinib in healthy subjects.
Narasimhan NI; Dorer DJ; Niland K; Haluska F; Sonnichsen D
J Clin Pharm Ther; 2013 Dec; 38(6):440-4. PubMed ID: 23888935
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang
Sun ML; Liu HJ; Luo XD; Wang Y; Zhang W; Liu C; Wang X
Drugs R D; 2022 Mar; 22(1):51-60. PubMed ID: 35061235
[TBL] [Abstract][Full Text] [Related]
7. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioequivalence study of montelukast sodium oral soluble film and chewable tablet in healthy Chinese volunteers: randomized trials under fasting and fed conditions.
Zhu G; Wang L; Han S; Peng H; Tong M; Gu X; Hu H; Wang Y; Lv Z; He X
Ann Transl Med; 2023 Jan; 11(2):93. PubMed ID: 36819512
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wang Y; Liu Y; Tang L; Gao J; Li H; Dai X; Chen R; Wang F
Clin Pharmacol Drug Dev; 2024 Apr; 13(4):360-366. PubMed ID: 38226890
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic dose proportionality between two strengths (12.5 mg and 25 mg) of doxylamine hydrogen succinate film-coated tablets in fasting state: a single-dose, randomized, two-period crossover study in healthy volunteers.
Videla S; Cebrecos J; Lahjou M; Wagner F; Guibord P; Xu Z; Cabot A; Encabo M; Encina G; Sicard E; Sans A
Drugs R D; 2013 Jun; 13(2):129-35. PubMed ID: 23633146
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study.
Wu ZX; Wang CJ; Shi P; Liu YP; Li T; Sun FF; Fu Y; Gao XM; Ma YP; Cao Y
Drugs R D; 2023 Jun; 23(2):121-127. PubMed ID: 37012461
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study.
Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415
[TBL] [Abstract][Full Text] [Related]
16. Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males.
Li J; Tan Y; Li K; Hui AM; Wu Z; Han P; Wei Z; Qiu J; Diao L; Wang X
Adv Ther; 2023 Mar; 40(3):1074-1086. PubMed ID: 36627544
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
[TBL] [Abstract][Full Text] [Related]
18. Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults.
Qin H; Tan Y; Diao L; Hui AM; Wu Z; Zhou Y; Sun J; Xiang X; Qiu J; Hu W
Drugs R D; 2023 Dec; 23(4):465-473. PubMed ID: 37934354
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence Study of Capsules versus Film Tablets Containing Rivaroxaban in Healthy Caucasian Subjects under Fasting and Fed Conditions.
Sözer G; Inal A; Sezer Z; Martin W; Ottmann E; Reinsch M; Koru SA
Clin Pharmacol Drug Dev; 2024 Mar; 13(3):281-287. PubMed ID: 37997509
[TBL] [Abstract][Full Text] [Related]
20. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
Lin TY; Yang MH; Chang FY
Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
